Listed

Vivos Therapeutics, Inc.

VVOSNasdaqCIK 1716166HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.2m, Q2 FY2026
Operating income−$4.8m, Q2 FY2026
Net income−$5.5m, Q2 FY2026
Vivos Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k3,301Revenue, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure3,248Revenue, Q4 FY2023, three months to 2023-12-31$3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure3,419Revenue, Q1 FY2024, three months to 2024-03-31$3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure4,054Revenue, Q2 FY2024, three months to 2024-06-30$4.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure3,860Revenue, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure3,698Revenue, Q4 FY2024, three months to 2024-12-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure3,016Revenue, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure3,820Revenue, Q2 FY2025, three months to 2025-06-30$3.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure6,783Revenue, Q3 FY2025, three months to 2025-09-30$6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure3,824Revenue, Q4 FY2025, three months to 2025-12-31$3.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure5,141Revenue, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure5,153Revenue, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Cost of revenue$k100Cost of revenue, Q3 FY2023, three months to 2023-09-30$100.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2023-11-14, accession 0001493152-23-041150.Report this figure5,330Cost of revenue, Q4 FY2023, three months to 2023-12-31$5.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure100Cost of revenue, Q1 FY2024, three months to 2024-03-31$100.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$k1,747Gross profit, Q3 FY2023, three months to 2023-09-30$1.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure2,089Gross profit, Q4 FY2023, three months to 2023-12-31$2.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure1,937Gross profit, Q1 FY2024, three months to 2024-03-31$1.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure2,651Gross profit, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure2,334Gross profit, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure2,097Gross profit, Q4 FY2024, three months to 2024-12-31$2.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure1,509Gross profit, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure2,110Gross profit, Q2 FY2025, three months to 2025-06-30$2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure3,937Gross profit, Q3 FY2025, three months to 2025-09-30$3.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure2,988Gross profit, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure3,059Gross profit, Q1 FY2026, three months to 2026-03-31$3.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure2,953Gross profit, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Research and development$k100Research and development, Q3 FY2023, three months to 2023-09-30$100.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-14, accession 0001493152-23-041150.Report this figure(100)Research and development, Q4 FY2023, three months to 2023-12-31−$100.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure100Research and development, Q1 FY2024, three months to 2024-03-31$100.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$k(3,640)Operating income, Q3 FY2023, three months to 2023-09-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure(4,133)Operating income, Q4 FY2023, three months to 2023-12-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure(3,785)Operating income, Q1 FY2024, three months to 2024-03-31−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure(1,936)Operating income, Q2 FY2024, three months to 2024-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure(2,645)Operating income, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(2,806)Operating income, Q4 FY2024, three months to 2024-12-31−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(3,918)Operating income, Q1 FY2025, three months to 2025-03-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(4,865)Operating income, Q2 FY2025, three months to 2025-06-30−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure(4,734)Operating income, Q3 FY2025, three months to 2025-09-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(6,382)Operating income, Q4 FY2025, three months to 2025-12-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(6,615)Operating income, Q1 FY2026, three months to 2026-03-31−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(4,825)Operating income, Q2 FY2026, three months to 2026-06-30−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported500Interest expense, Q3 FY2025, three months to 2025-09-30$500.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure800Interest expense, Q4 FY2025, three months to 2025-12-31$800.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure1,100Interest expense, Q1 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure1,100Interest expense, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Net income$k(2,093)Net income, Q3 FY2023, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure(4,259)Net income, Q4 FY2023, three months to 2023-12-31−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure(3,763)Net income, Q1 FY2024, three months to 2024-03-31−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(1,930)Net income, Q2 FY2024, three months to 2024-06-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(2,616)Net income, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(2,827)Net income, Q4 FY2024, three months to 2024-12-31−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(3,864)Net income, Q1 FY2025, three months to 2025-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(5,013)Net income, Q2 FY2025, three months to 2025-06-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure(5,400)Net income, Q3 FY2025, three months to 2025-09-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(6,894)Net income, Q4 FY2025, three months to 2025-12-31−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(7,682)Net income, Q1 FY2026, three months to 2026-03-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(5,481)Net income, Q2 FY2026, three months to 2026-06-30−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Diluted EPS$ per share(1.75)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figurenot reported(1.63)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure(0.60)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure(0.40)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figurenot reported(0.45)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(0.55)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure(0.49)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(0.31)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Basic EPS$ per share(1.75)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figurenot reported(1.63)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure(0.60)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure(0.40)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figurenot reported(0.45)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(0.55)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure(0.49)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figurenot reported(0.52)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(0.31)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure

Balance sheet

Cash and equivalents$1.8m, Q2 FY2026
Long-term debt$366.0k, Q2 FY2026
Shareholders' equity−$3.8m, Q2 FY2026
Vivos Therapeutics, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31period not labelled2025-06-10Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1.6Cash and equivalents, FY2023, at 2023-12-31$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001641172-25-001750.Report this figure2.6Cash and equivalents, Q1 FY2024, at 2024-03-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure6.9Cash and equivalents, Q2 FY2024, at 2024-06-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure6.3Cash and equivalents, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure6.3Cash and equivalents, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure2.3Cash and equivalents, Q1 FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure6.0Cash and equivalents, period not labelled, at 2025-06-10$6.0m. XBRL concept us-gaap:Cash. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure4.4Cash and equivalents, Q2 FY2025, at 2025-06-30$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure3.1Cash and equivalents, Q3 FY2025, at 2025-09-30$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure2.0Cash and equivalents, FY2025, at 2025-12-31$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure2.1Cash and equivalents, Q1 FY2026, at 2026-03-31$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure1.8Cash and equivalents, Q2 FY2026, at 2026-06-30$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Current assets$m2.5Current assets, FY2023, at 2023-12-31$2.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001750.Report this figure3.6Current assets, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure7.9Current assets, Q2 FY2024, at 2024-06-30$7.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure7.4Current assets, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure7.5Current assets, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure3.6Current assets, Q1 FY2025, at 2025-03-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figurenot reported6.7Current assets, Q2 FY2025, at 2025-06-30$6.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure5.8Current assets, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure4.4Current assets, FY2025, at 2025-12-31$4.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure4.8Current assets, Q1 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure4.2Current assets, Q2 FY2026, at 2026-06-30$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Total assets$m10.7Total assets, FY2023, at 2023-12-31$10.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001641172-25-001750.Report this figure11.8Total assets, Q1 FY2024, at 2024-03-31$11.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure15.8Total assets, Q2 FY2024, at 2024-06-30$15.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure15.3Total assets, Q3 FY2024, at 2024-09-30$15.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure15.3Total assets, FY2024, at 2024-12-31$15.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure11.3Total assets, Q1 FY2025, at 2025-03-31$11.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figurenot reported26.0Total assets, Q2 FY2025, at 2025-06-30$26.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure25.6Total assets, Q3 FY2025, at 2025-09-30$25.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure25.2Total assets, FY2025, at 2025-12-31$25.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure25.0Total assets, Q1 FY2026, at 2026-03-31$25.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure24.1Total assets, Q2 FY2026, at 2026-06-30$24.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Current liabilities$m7.3Current liabilities, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001750.Report this figure8.1Current liabilities, Q1 FY2024, at 2024-03-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure6.6Current liabilities, Q2 FY2024, at 2024-06-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure5.1Current liabilities, Q3 FY2024, at 2024-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure5.0Current liabilities, FY2024, at 2024-12-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure4.7Current liabilities, Q1 FY2025, at 2025-03-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figurenot reported6.4Current liabilities, Q2 FY2025, at 2025-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure7.4Current liabilities, Q3 FY2025, at 2025-09-30$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure18.1Current liabilities, FY2025, at 2025-12-31$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure17.9Current liabilities, Q1 FY2026, at 2026-03-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure20.4Current liabilities, Q2 FY2026, at 2026-06-30$20.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Total liabilities$m10.3Total liabilities, FY2023, at 2023-12-31$10.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001641172-25-001750.Report this figure11.2Total liabilities, Q1 FY2024, at 2024-03-31$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure9.5Total liabilities, Q2 FY2024, at 2024-06-30$9.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure7.7Total liabilities, Q3 FY2024, at 2024-09-30$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure7.3Total liabilities, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure6.9Total liabilities, Q1 FY2025, at 2025-03-31$6.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figurenot reported21.5Total liabilities, Q2 FY2025, at 2025-06-30$21.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure23.1Total liabilities, Q3 FY2025, at 2025-09-30$23.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure26.7Total liabilities, FY2025, at 2025-12-31$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure26.3Total liabilities, Q1 FY2026, at 2026-03-31$26.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure28.1Total liabilities, Q2 FY2026, at 2026-06-30$28.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported7.8Long-term debt, Q2 FY2025, at 2025-06-30$7.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure8.4Long-term debt, Q3 FY2025, at 2025-09-30$8.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure0.5Long-term debt, FY2025, at 2025-12-31$469.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure0.4Long-term debt, Q1 FY2026, at 2026-03-31$418.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure0.4Long-term debt, Q2 FY2026, at 2026-06-30$366.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported0.2Current portion of debt, Q2 FY2025, at 2025-06-30$157.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure0.3Current portion of debt, Q3 FY2025, at 2025-09-30$339.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure8.4Current portion of debt, FY2025, at 2025-12-31$8.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure7.3Current portion of debt, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure7.8Current portion of debt, Q2 FY2026, at 2026-06-30$7.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure
Shareholders' equity$m0.4Shareholders' equity, FY2023, at 2023-12-31$411.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure0.6Shareholders' equity, Q1 FY2024, at 2024-03-31$582.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure6.3Shareholders' equity, Q2 FY2024, at 2024-06-30$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure7.7Shareholders' equity, Q3 FY2024, at 2024-09-30$7.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure8.0Shareholders' equity, FY2024, at 2024-12-31$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-04-15, accession 0001493152-26-016854.Report this figure4.4Shareholders' equity, Q1 FY2025, at 2025-03-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figurenot reported4.6Shareholders' equity, Q2 FY2025, at 2025-06-30$4.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure2.5Shareholders' equity, Q3 FY2025, at 2025-09-30$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure(1.5)Shareholders' equity, FY2025, at 2025-12-31−$1.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure(1.1)Shareholders' equity, Q1 FY2026, at 2026-03-31−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(3.8)Shareholders' equity, Q2 FY2026, at 2026-06-30−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure

Cash flow

Operating cash flow−$3.1m, Q2 FY2026
Capital expenditure$416.0k, Q2 FY2026
Vivos Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,800)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045888. Derived: 9-month figure less the 6-month figure.Report this figure(2,748)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure(2,516)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure(3,048)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-19, accession 0001641172-25-024832. Derived: 6-month figure less the 3-month figure.Report this figure(4,187)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001493152-25-024253. Derived: 9-month figure less the 6-month figure.Report this figure(2,940)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(3,796)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(3,494)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001493152-26-038336. Derived: 6-month figure less the 3-month figure.Report this figure(4,161)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001493152-25-024253. Derived: 9-month figure less the 6-month figure.Report this figure(3,812)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure(6,010)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure(3,148)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001493152-26-038336. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k154Capital expenditure, Q3 FY2023, three months to 2023-09-30$154.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001493152-24-045888. Derived: 9-month figure less the 6-month figure.Report this figure165Capital expenditure, Q4 FY2023, three months to 2023-12-31$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001641172-25-001750. Derived: 12-month figure less the 9-month figure.Report this figure151Capital expenditure, Q1 FY2024, three months to 2024-03-31$151.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure60.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-19, accession 0001641172-25-024832. Derived: 6-month figure less the 3-month figure.Report this figure192Capital expenditure, Q3 FY2024, three months to 2024-09-30$192.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-19, accession 0001493152-25-024253. Derived: 9-month figure less the 6-month figure.Report this figure165Capital expenditure, Q4 FY2024, three months to 2024-12-31$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure122Capital expenditure, Q1 FY2025, three months to 2025-03-31$122.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure771Capital expenditure, Q2 FY2025, three months to 2025-06-30$771.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001493152-26-038336. Derived: 6-month figure less the 3-month figure.Report this figure(83.0)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-19, accession 0001493152-25-024253. Derived: 9-month figure less the 6-month figure.Report this figure1,531Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-15, accession 0001493152-26-016854. Derived: 12-month figure less the 9-month figure.Report this figure18.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure416Capital expenditure, Q2 FY2026, three months to 2026-06-30$416.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001493152-26-038336. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)17.68m, Q2 FY2026
Vivos Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30849,446 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041150.Report this figure1.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31990,669 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001493152-24-019247.Report this figure1.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,197,258 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-032240.Report this figure1.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,197,258 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045888.Report this figure2.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-312,308,154 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010874.Report this figure3.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,228,363 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-19, accession 0001641172-25-024832.Report this figure6.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-306,615,320 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure8.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,595,288 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure9.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-309,087,202 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure11.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3010,963,590 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001493152-25-024253.Report this figure14.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3114,634,115 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-20, accession 0001493152-26-024650.Report this figure17.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3017,681,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure

Shares outstanding: 20.12mShares outstanding, period not labelled, at 2026-08-1320,118,023 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038336.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.